1092351-10-4

1092351-10-4 structure

Name: PSB 603
Chemical Name: 8-(4-(4-(4-chlorophenyl)piperazine-1-sulfonyl)phenyl)-1-propyl-3,7-dihydropurine-2,6-dione
CAS Number: 1092351-10-4
Molecular Formula: C₂₄H₂₅ClN₆O₄S
Molecular Weight: 529.01
Catalog: Signaling Pathways GPCR/G Protein Adenosine Receptor
Create Date: 2016-09-16 13:44:43
Modify Date: 2025-08-25 17:24:04
PSB-603 is a potent and selective adenosine A2B receptor antagonist exhibiting a Ki value of 0.553 nM at the human A2B receptor and virtually no affinity for the human and rat A1 and A2A and the human A3 receptors up to a concentration of 10 μM[1].

Name	8-(4-(4-(4-chlorophenyl)piperazine-1-sulfonyl)phenyl)-1-propyl-3,7-dihydropurine-2,6-dione
Synonyms	BNTX maleate

Description	PSB-603 is a potent and selective adenosine A2B receptor antagonist exhibiting a Ki value of 0.553 nM at the human A2B receptor and virtually no affinity for the human and rat A1 and A2A and the human A3 receptors up to a concentration of 10 μM[1].
Related Catalog	Research Areas >> Inflammation/Immunology Signaling Pathways >> GPCR/G Protein >> Adenosine Receptor
In Vitro	PSB-603 inhibits human A2B receptor in Jurkat T cells with an IC50 of 1.13 nM[1]. PSB-603 inhibits human, rat, and mouse A2B receptors with Ki values of 0.553, 0.355, and 0.265 nM, respectively[2]. PSB-603 (100 nM; 24 hours) antagonizes NECA (an adenosine receptor agonist; 1µM) inhibited interferon-γ and stimulated interleukin-6 production[3]. Cell Viability Assay[3] Cell Line: Peripheral T cells Concentration: 100 nM Incubation Time: 24 hours Result: Significantly inhibited NECA stimulated IL-6 release ≈3-fold.
In Vivo	PSB-603 shows anti-inflammatory effect in local and systemic inflammation models. PSB-603 (5 mg/kg b.w. ip) significantly reduces inflammation in two mice models of inflammation (local and systemic). PSB-603 significantly decreases levels of the inflammatory cytokines IL-6, TNF-α and of ROS in the inflamed paw and reduces inflammation of the peritoneum by significantly decreasing the infiltration of leukocytes[4]. PSB-603 is administered as suspensions in 1 % Tween 80[4]. Animal Model: Adult male Albino Swiss mice, CD-1, weighing 25-30 g[4] Dosage: 1, 5 or 10 mg/kg Administration: Administered intraperitoneally (ip), prior to carrageenan injection Result: Carrageenan-induced edema model. The increase in paw oedema was significantly inhibited in all groups receiving PSB-603. The dose of 5 mg/kg turned out to be the most active.
References	[1]. Thomas Borrmann, et al. 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A_2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. J Med Chem. 2009 Jul 9;52(13):3994-4006. [2]. Mohamad Wessam Alnouri, et al. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal. 2015 Sep;11(3):389-407. [3]. Nadine Borg, et al. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming. Circulation. 2017 Jul 18;136(3):297-313. [4]. Magdalena Kotańska, et al. PSB 603 - a known selective adenosine A_2B receptor antagonist-has anti-inflammatory activity in mice. Biomed Pharmacother. 2021 Mar;135:111164.

Molecular Formula	C₂₄H₂₅ClN₆O₄S
Molecular Weight	529.01
Exact Mass	528.13500
PSA	132.54000
LogP	3.73790

Hazard Codes	Xi

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1092351-10-4	1407632-07-8
1802226-78-3	1052087-90-7
2189700-03-4	55476-47-6
66295-57-6	2094630-35-8
2332835-02-4	152529-79-8
2228218-29-7	2639161-64-9
434928-99-1	2228743-40-4
1514927-85-5	78594-85-1
2446931-64-0	2228176-92-7
2306277-29-0	2590064-51-8